Evidence Hub

Antibacterial evaluation of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate against Klebsiella pneumoniae strains: an in silico and in vitro study

Ana Isabele Andrade Neves, Cássio Ilan Soares Medeiros, J. O. Lemos, M. H. F. Rocha, Gabriel Neves Alves, W. K. S. Lima, L. A. RAMALHO, Francisco Patrício de Andrade Júnior et al.

Brazilian Journal of Biology, 2026

Abstract

Abstract Pressure ulcers (PUs) carry a high risk of infection by multidrug-resistant pathogens, including Klebsiella pneumoniae. This study evaluated the antibacterial activity of (E)-3,7-dimethylocta-2,6-dien-1-yl acetate (TSM-16), a synthetic derivative of geraniol, against various strains of K. pneumoniae. In silico analyses were performed using PASS online®, Molinspiration®, AutoDock, PyMol, and Discovery Studio, in addition to in vitro broth microdilution tests to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and disk diffusion assays to evaluate the combination of TSM-16 with conventional antibacterials. The in silico results indicated that TSM-16 complies with Lipinski’s Rule and has good bioavailability. In in vitro tests, the compound exhibited moderate to strong antibacterial activity (MIC 500-1000 µg/mL), a bacteriostatic profile (MBC >1000 µg/mL), and a predominance of synergistic effects when combined with synthetic antibacterials. These findings suggest that TSM-16 has potential as a safe antibacterial agent, serving as a basis for the development of new drugs against multidrug-resistant strains of K. pneumoniae.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free